Antipsychotic use up among U.S. medicaid-enrolled youth

September 14, 2012
Antipsychotic use up among U.S. medicaid-enrolled youth
There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

(HealthDay)—There has been a substantial increase in antipsychotic use among Medicaid-enrolled children in recent years, with the increase partially driven by youth with attention-deficit/hyperactivity disorder (ADHD) and those with multiple diagnoses, according to a study published online Sept. 4 in Health Services Research.

Meredith Matone, M.H.S., from the Children's Hospital of Philadelphia, and colleagues used Medicaid Analytic Extract files for 50 states and the District of Columbia to describe the relationship between mental health diagnosis and treatment with in children from 2002 to 2007.

The researchers found that there was a 62 percent increase in antipsychotic use, reaching 354,000 youth by 2007. Proportionally, youth with bipolar disorder, schizophrenia, and autism were more likely to receive antipsychotics, while the largest consumers of antipsychotics over time were youth with and those with three or more mental health diagnoses. By 2007, 50 percent of total antipsychotic use was for youth with ADHD and one in seven antipsychotic users were youth with a sole diagnosis of ADHD.

"This national analysis revealed persistent growth in second-generation antipsychotic use among U.S. -enrolled children during the past decade," the authors write. "In the context of a complex relationship between childhood behavior, diagnosis, and treatment, future research will need to more broadly examine the efficacy and safety of second-generation antipsychotic use in pediatric populations and the potential consequences of efforts to restrict their use."

Explore further: All types of antipsychotic drugs increase the risk of stroke

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

More kids taking antipsychotics for ADHD: study

August 7, 2012

(HealthDay) -- Use of powerful antipsychotic medications such as Abilify and Risperdal to control youngsters with attention-deficit/hyperactivity disorder (ADHD) and other behavior problems has skyrocketed in recent years, ...

Recommended for you

Psychosis associated with low levels of physical activity

August 25, 2016

A large international study of more than 200,000 people in nearly 50 countries has revealed that people with psychosis engage in low levels of physical activity, and men with psychosis are over two times more likely to miss ...

Sleep makes relearning faster and longer-lasting

August 22, 2016

Getting some sleep in between study sessions may make it easier to recall what you studied and relearn what you've forgotten, even 6 months later, according to new findings from Psychological Science, a journal of the Association ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.